The Diagnostic Performance of BMO-MRW and RNFL Thickness and Their Combinational Index Using Artificial Neural Network
The Comparison of Bruch's Membrane Opening-minimum Rim Width and Retinal Nerve Fiber Layer Thickness and Their Combinational Index Using Artificial Neural Network
1 other identifier
observational
402
1 country
1
Brief Summary
This study evaluates the relationship between BMO-MRW and RNFL thickness measured by OCT. SD-OCT exam will be performed to all patients in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2015
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2016
CompletedFirst Submitted
Initial submission to the registry
August 17, 2017
CompletedFirst Posted
Study publicly available on registry
August 22, 2017
CompletedAugust 25, 2017
August 1, 2017
1.4 years
August 17, 2017
August 24, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Bruch's membrane opening - minimum rim width (BMO-MRW)
SD-OCT will be performed to the patients to measure BMO-MRW by trained glaucoma specialist.
5~10 minutes
Secondary Outcomes (1)
Retinal nerve fiber layer (RNFL) thickness
5~10 minutes
Study Arms (2)
Normal subject
Measure BMO-MRW and RNFL with SD-OCT. If the BMO-MRW and RNFL is within the normal range and those with no history of ocular disease, an intraocular pressure \< 21 mmHg, an absence of glaucomatous optic disc appearance, and a normal visual field, they will be classified into normal group.
Glaucoma patients
Measure BMO-MRW and RNFL with SD-OCT. If the BMO-MRW and RNFL is below the normal range and those with glaucomatous optic disc and two consecutive abnormal visual field test results with open angles on gonioscopy, glaucomatous optic neuropathy, RNFL defects congruent with visual field defects, they will be classified into glaucoma patients.
Interventions
SD-OCT was performed to all subjects to measure BMO-MRW and RNFL thickness by trained glaucoma specialist. It takes about 5 to 10 minutes. The foveal location was manually detected with a live B-scan, followed by defining BMO center. A radial pattern containing 24 angular, equidistant, high-resolution 15° B-scans centered on the BMO was used to compute the neuroretinal rim parameters. The BMO points and ILM were identified and marked in each B-scan with automated software (Glaucoma Module Premium Edition, version 6.0; Heidelberg Engineering). After radial scan completed, 3 consecutive circumpapillary B-scans were followed to measure RNFL thickness at diameter of 3.5, 4.1 and 4.7mm. BMO-MRW and RNFL thickness was automatically computed globally and sectorally.
Eligibility Criteria
The patients who visited Pusan National University Hospital glaucoma clinic.
You may qualify if:
- Age \> 18 years with a clear cornea and clear ocular media
- BCVA ≥ 20/40
- Refractive error within ± 6.0 diopters (D) of 0 and astigmatism ± 3.0 D of 0
You may not qualify if:
- uveitis
- secondary glaucoma
- corneal abnormalities
- non-glaucomatous optic neuropathies
- previous trauma
- ocular surgery or laser treatment
- any other eye disease except glaucoma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pusan National University Hospital
Busan, 49214, South Korea
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Jiwoong Lee, M.D., Ph.D
Medical Research Institute, Pusan National University Hospital, Busan, Korea
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 17, 2017
First Posted
August 22, 2017
Study Start
August 1, 2015
Primary Completion
December 31, 2016
Study Completion
December 31, 2016
Last Updated
August 25, 2017
Record last verified: 2017-08
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, CSR
- Time Frame
- Data will be available within 12 months after study published.
- Access Criteria
- Data access requests will be reviewed by an external independent review panel (PNUH IRB) and if they approve, data will be provided.
De-identified individual participants data for all primary and secondary outcome measures will be shared.